Chronic Idiopathic Urticaria (CIU) Treatment Market is segmented By Route of Administration (Subcutaneous, Intravenous, Oral), By Molecule Type (Monoc....
The major players operating in the Chronic Idiopathic Urticaria (CIU) Treatment Market include Taizhou Mabtech Pharmaceutical Co. Ltd., Celldex Therapeutics, Allakos, Novartis, GlaxoSmithKline, Regeneron Pharmaceuticals, Sanofi, AstraZeneca, UCB Pharma, and Teva Pharmaceuticals.
Chronic Idiopathic Urticaria (CIU) Treatment Market